NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy

NCT02051894 · clinicaltrials.gov ↗

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Circulatory Failure

Interventions

DRUG: Dobutamine

Sponsor

Brighton and Sussex University Hospitals NHS Trust

Collaborators

[object Object]